| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to biochemistry. The invention also involves using antibodies for treating or preventing IL-4 and (or) IL-13 mediated diseases or disorders, including allergic asthma and dermatitis.EFFECT: humanised anti-IL-4 and anti-IL-13 antibodies and their fragments, which specifically bind to IL-4 and IL-13 are presented.32 cl, 2 dwg, 8 tbl, 8 ex |
